Alternative Bowel Preparation Options to GoLYTELY (Polyethylene Glycol)
Several effective alternatives to GoLYTELY (4L PEG-ELS) exist for bowel preparation, with low-volume PEG formulations being equally effective in healthy non-constipated individuals while offering better tolerability and patient compliance. 1
FDA-Approved Alternative Options
Low-Volume PEG-Based Preparations
MoviPrep (2L PEG-ELS with ascorbate and sodium sulfate) 1
- Contains supplemental ascorbate and sodium sulfate
- Administered as split-dose for optimal effectiveness
SUPREP (Oral Sulfate Solution - OSS) 1
- FDA-approved for split-dose administration only
- Clinical trials show comparable cleansing efficacy to PEG-ELS (98.4% vs 89.6%)
- Lower volume improves patient tolerance
Prepopik (Sodium picosulfate/magnesium citrate) 1
- Recently introduced to US market
- Most effective when administered as split-dose
- Similar cleansing efficacy to PEG-ELS
SUCLEAR (Combination of PEG-ELS and OSS) 1
Prescription Tablet Option
- Osmo-Prep (Sodium phosphate tablets) 1
- Note: Contains boxed warning about risk of acute phosphate nephropathy
- Should be avoided in patients with renal insufficiency
Evidence-Based Administration Methods
Split-Dose Administration
- Split-dose regimens (taking half the preparation the evening before and half the morning of the procedure) significantly improve bowel cleanliness compared to single-dose administration
- Studies show 4.38 times higher odds of adequate cleansing with split dosing 1
Low-Volume PEG with Adjuncts
2L PEG + Bisacodyl combination 2
- Equally effective as 4L PEG-ELS
- Higher patient compliance (93% vs 66% completed full preparation)
- Significantly better patient comfort scores
MiraLAX (PEG-3350) + Gatorade + Bisacodyl 3
- 238g MiraLAX in 64 oz Gatorade plus four 5mg bisacodyl tablets
- Achieved excellent/good bowel cleansing in 93.3% vs 89.3% with GoLYTELY
- Better patient acceptance in community setting
Patient-Specific Considerations
Special Populations
For patients with renal insufficiency, congestive heart failure, or advanced liver disease:
- PEG-ELS preparations are preferred due to their iso-osmotic properties 1
- Avoid sodium phosphate preparations due to risk of electrolyte disturbances
For pediatric patients:
- PEG-3350 at 1.5g/kg/day for 4 days before procedure 1
- Clear liquid diet on the final day
- May be combined with enemas in older children
Palatability Considerations
- Lactulose may be considered in resource-limited settings 4
- Comparable bowel cleansing to PEG (BBPS score 6.25 vs 6.35)
- 90% of patients found it more palatable than PEG
- Minimal electrolyte disturbances
Common Pitfalls and Solutions
Inadequate preparation despite compliance
- Consider large-volume enemas before sedation
- Through-the-scope enema technique during colonoscopy
- Rescheduling for next-day colonoscopy reduces risk of repeat failure 1
Poor tolerance of preparation volume
- Switch to split-dose regimen
- Consider low-volume PEG plus adjunctive medications
- Use taste enhancers when permitted
Constipation management
- For opioid-induced constipation, use stimulant laxatives with or without stool softeners 1
- PEG with water twice daily is effective for maintenance
Remember that regardless of the preparation chosen, the quality of bowel cleansing directly impacts the ability to detect lesions and determines appropriate screening/surveillance intervals. The goal is to achieve a preparation that allows detection of lesions >5mm throughout the colon 1.